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The presence of herpes simplex virus (HSV-1) DNA in the trigeminal ganglia of latently infected mice was detected by 
an in situ DNA polymerase chain reaction (PCR), which includes a DNA:DNA hybridization step (indirect in situ PCR). These 
results were compared to the number of neurons possessing the HSV-1 latency associated transcript (LAT), as detected 
by in situ RNA hybridization with LAT probes. Sensitivity assays were shown to detect a single copy cellular gene in 48% 
of neuronal cell bodies. The results suggest that in situ PCR is an effective method to locate and detect HSV-1 within 
latently infected neurons. Moreover, the number of neurons found to be harboring HSV-1, by the method of in situ PCR, 
which does not depend upon virus gene expression, is within threefold of the number detected by in situ hybridization for 
LAT. Therefore, this report describes the first detection of HSV-1 DNA in latently infected murine trigeminal ganglia by the 
method of indirect in situ PCR, and compares the findings to the number of neurons expressing LAT, as assessed by 
conventional in situ hybridization. © 1995 Academic Press, Inc. 
In humans and in animal models, herpes simplex virus 
(HSV-1) gains access to host peripheral nerves after a 
period of productive infection in epithelial cells near the 
site of entry. The virus then establishes a latent infection 
in the neuron and can reside in a nonproductive state 
for the rest of the life of the host (28). From time to time, 
however, infectious virus reappears near the entry site, 
causing productive infection in epithelial cells. In healthy 
people, this "reactivation" is limited by the host immune 
response (24). 
The mouse has been used as a model of HSV-1 latency 
(17, 26). In one mouse model, virus is introduced via 
the eye (see 7). After acute replication of the virus has 
subsided, lesions on the skin and eye disappear and 
virus cannot be recovered in eye washings. Latent virus 
in trigeminal neurons is recognized by recovery of viral 
DNA from tissue homogenates or explanation of the tri- 
geminal ganglia and cocultivation with permissive indica- 
tor cells. Virus released from infected neurons infects 
monolayers of permissive tissue culture cells and is rec- 
ognized by characteristic ytopathic effect (see 23, 25). 
The localization of virus to specific latently infected 
neurons has, to this time, depended upon in situ methods 
to detect the production of a virus gene product. Most 
consistent is the detection of the latency associated tran- 
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script (LAT) by in situ RNA hybridization (6, 7, 26). Al- 
though LAT is produced in productively infected cells, 
it is apparently the only set of viral transcripts which 
accumulate in latently infected ceils (see 7). Detection of 
viral DNA by in situ hybridization has not been consistent. 
This is probably due to the low abundance of viral DNA 
per latently infected neuron. The LATs, however, accumu- 
late to a high per cell copy number. Therefore, the ex- 
pression of LAT, or other artificial reporter products such 
as fl-galactosidase (/~-gal) and/3-glucuronidase (/~-gluc), 
transcribed under the control of the LAT promoter, has 
been the only way to visualize neurons harboring latent 
virus (11, 20, 30). 
The inability to detect HSV-1 DNA, in situ, in latently 
infected cells, has been a tremendous limitation. First, it 
is possible that latently infected neurons which express 
viral LAT represent only a small subset of the true total 
number of latently infected cells. That is, there may be 
many more latently infected neurons than there are LAT 
expressing neurons. Second, the study of LAT null mutant 
viruses, which by definition are unable to produce or 
accumulate LAT, has been frustrated by the inability to 
detect virus by means other than LAT hybridization. Some 
LAT mutants have been genetically engineered to ex- 
press reporter products (such as/3-gal or #-gluc) under 
the control of the LAT promoter to allow for localization of 
virus in latent cells, and this has overcome the limitations 
stated to some extent (11, 20, 30). However, each mutant 
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must be "customized" by insertion of a reporter gene 
under LAT promoter control. Most seriously, is the fact 
that LAT promoter function must still occur for detection 
to be possible. Recent data has shown that the LAT 
promoter may only be.functional for a limited period of 
time and if, in the case of p-gal (15), the reporter product 
is very stable, a false account of the number of neurons 
harboring viral DNA may be assumed. If LAT promoter 
function and latent infection do not occur in every tatently 
infected cell, these systems may again underestimate 
the true numbers and locations of latently infected cells. 
A system that allows for the detection of HSV-1 DNA 
in situ would overcome many of these limitations. Several 
groups have reported the technique of in situ polymerase 
chain reaction (PCR) in the detection of viral nucleic acid 
and in genome rearrangements in both suspended cells 
and fixed tissue sections (10, 12, 19). For example, the 
presence of human immunodeficiency virus (HIV) provi- 
rus, latent in the mononuclear cells of asymptomatic peo- 
ple, has been detected by an in situ PCR technique (1) 
and as few as two copies per cell of the provirus genome 
have been detected (2). In situ PCR has also recently 
been used to detect HSV-1 sequences in persistently 
infected corneal tissue (18) and HSV-2 sequences in la- 
tently infected central nervous tissue and trigeminal gan- 
glia (9). Detection of HSV-2 sequences in trigeminal gan- 
glia (9) was accomplished by the method of direct in situ 
PCR, where labeled nucleotides are incorporated during 
the PCR reaction. However, although this method is 
highly sensitive, it has been shown to sometimes result 
in higher background and false positives (12). Moreover, 
the detection of HSV-1 in latently infected murine trigemi- 
nat ganglia by any method of in situ PCR has not been 
reported. As biological differences exist between HSV-1 
and HSV-2, it cannot be assumed that the two viruses 
will establish latency in the same manner. Therefore it 
is important o demonstrate the presence of HSV-1 se- 
quences in trigeminal ganglia and to explore the possibil- 
ity of "indirect" detection methods. These differences 
make the detection of HSV-1 in the trigeminal ganglia by 
the method of indirect in situ PCR significant. Our report 
correlates the detection of single copy mouse genes with 
detection of HSV-1 sequences in the same trigeminal 
tissue by the method of indirect in situ PCR and extends 
and reinforces the other study (9). 
Fifteen Balb/c mice were inoculated via the eye with 
10~-10 ePFU of HSV-1 strain 17, as in (3). Thirty days after 
infection, at a time when latency has been established, 
surviving mice were sacrificed and trigeminal ganglia 
were removed and tested for (i) the ability to reactivate 
virus in the explant cocultivation assay as in (3), (ii) the 
presence of HSV-1 DNA, or (iii) the presence of HSV-1 
LAT. The cocultivation of eight trigeminal ganglia with 
permissive CV-1 cells revealed that all mice tested con- 
tained reactivatable virus which appeared within 10 days 
postexplanation (data not shown). The remaining trigemi- 
nal ganglia were prepared for in situ analysis of either 
viral DNA or LAT. Experiments to detect a mouse single 
copy gene (all-l) and hepatitis B virus (HBV) sequences 
were also done, to measure the sensitivity and specificity 
of the system, respectively. 
Trigeminal ganglia were removed, washed quickly 
(less than 5 min) in 1X PBS (150 mM NaCI, 10 mM 
Na2HPO4, 1.5 mM KH2PO4, pH 7.12) and placed overnight 
in PLP fixative (2% paraformaldehyde, 75 mM lysine, 2 
mg/ml NalO4, in 75 mM phosphate buffer, pH 7.4). The 
next day, thetissue was dehydrated by placement in 70% 
ethanol for 24 hr. Following this treatment, the ganglia 
were pooled in sets of four and placed in paraffin as in 
(17). For both in situ PCR and RNA in situ hybridizations, 
4-#m sections were cut using a microtome apparatus 
and the slices briefly incubated in distilled water. The 
sections were then placed either on slides destined for 
in situ hybridization or on 3-aminopropyl-triethoxysilane 
(Sigma Chemicals, St. Louis, MO)-coated slides destined 
for in situ PCR (Erie Scientific, Porthsmouth, NH). For 
in situ PCR, paraffin was removed by incubation (room 
temperature, twice) in xylene for 5 to 10 min, followed by 
a 100% ethanol wash. After heating to 105 ° for 90 sec 
and refixing in 2% paraformaldehyde (overnight), slides 
were washed once in 3x PBS and then twice in 1X PBS, 
where 1X PBS is 150 mM NaCI, 10 mM Na2HPO4, 1.5 
mM KH2PO4, pH 7.12. Endogenous peroxidase activity 
was removed by incubation in 0.3% hydrogen peroxide 
solution, overnight. Slides were then digested with pro- 
teinase K (Sigma) (5 ffg/ml at room temperature) for 75 
to 90 min. After proteinase K treatment, slides were 
placed on a 96 ° heat block for 2 min and washed thor- 
oughly in sterile double-distilled water. Slides that were 
to be used to detect the all-1 gene were treated with 
RNase (100 #g/ml in 100 mM EDTA for 1 hr) prior to the 
amplification reaction. As a control, several sets of slides 
to be used for the detection of HSV-1 DNA sequences 
were also treated with RNase. 
PCR amplification was conducted using DNA primers 
specific for the HSV-1 polymerase gene (UL30), the HBV 
X gene, orthe mouse all-1 gene. The HSV-1 primers were 
purchased from Synthetic Genetics (San Diego, CA) and 
hybridized to nucleotides 3060-3081 (5'-CATCACCGA- 
CCCGGAGAGGGAC-3') and 3130-315t (5'-GGGCCA- 
GGCGCTTG-FI-GGTGTA-3') of the HSV-t genome using 
the numbering system of (13). These primers lie outside 
of the LAT region and have been used successfully to 
detect LAT null mutants (data not shown). Primers used 
to detect the mouse all-1 gene were a gift from Q. Ma 
and A. Buchberg (14). The upstream murine primer is 1- 
23 (5'-GGCAGCTTAGCATCCTG-FFAT-3') and the down- 
stream primer is 1-25 (5'-GCGTAGACTAAGGCACACAT- 
3'). HBV primers are as in (4). The PCR mix consisted of 
10 #M of each dNTP, 2.5 mM MgCI, 20 mM Tris-HCI 
(pH 8.8 at 25°), 50 mM KCI, 1 #M primers, and 1 unit of 
Taq DNA polymerase (Promega, Madison, WI) per gangli- 
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onic section. Approximately 20 #1 of mix was added to 
the well of each slide and covered with a glass coverslip. 
The coverslips were carefully sealed using clear nail 
polish. The PCR reaction consisted of 3-rain cycles of 1- 
min incubation~ at 94, 55, and 72 °, respectively. The 3- 
rain cycle was repeated 30 times. A final cycle brought 
the reaction to 4 ° . Amplification was carried out either on 
a Perkin-Elmer-Cetus (Norwalk, CT) or a MJ Research 
thermocycler (Watertown, MA) as described in (2). After 
amplification, slides were dipped in 100% ethanol (10- 
20 mini and the coverslips removed by the use of a razor 
blade. Hybridization reactions were conducted using the 
oligonucleotide probes at 25 ng/ml. All oligonucleotide 
probes were biotinylated at the 5' end. The HSV-1 probe 
was purchased from Synthetic Genetics as part of a HSV- 
1 detection kit and is complementary to nucleotides 
3080-3116 (5'-GACI-FFGTCCTCACCGCCGAACTGAG- 
OAG-3) of the HSV 1 DNA polymerase gene. The murine 
aft-I probe (5'-TCACGAGCACATCGGCACAATCACCAG- 
CAO-3') was synthesized by Genosys Inc. (The Wood- 
lands, TX) using known sequences within the all-1 gene 
(14). Hybridizations were done in a solution of 50% deion- 
ized formamide, 0.1% salmon sperm DNA, 0.1% SDS, 2x  
SSO, 10x Denhardt at 48 ° for 4 -6  hr. SSC (2x) i s  0.3 M 
NaCI, 0.33 M NaOitrate, pH 7.0, and 10X Denhardt is 
0.25% Ficoll, 0.25% polyvinyl pyrrolidone, and 0.25% bo- 
vine serum albumin, pentax fraction X, in water, as de- 
scribed in (3). Hybridization reactions were detected by 
incubation with a streptavidin-peroxidase complex 
(Sigma, 33 #g/ml in PBS) for 1 hr at 37 ° . Reactions were 
developed in 0.15% hydrogen peroxide, 5% 3'-amino-9'- 
ethylene carbozone, 50 mM acetate (pH 5.0) solution 
for 10 min. The reactions were visualized under a light 
microscope by looking for red-granular staining over 
cells. 
To determine the sensitivity of the PCR system, amplifi- 
cation and detection of a mouse single copy gene was 
attempted. The murine all-1 primers were initially tested 
on DNA from mock- and HSV-l-infected trigeminal gan- 
glia in liquid PCR reactions. They were found to be both 
sensitive and specific (giving only the expected single 
band) and were deemed acceptable for use in an in situ 
POR reaction (data not shown). Figure 1 shows the re- 
sults of amplification of the mouse all-1 gene within cells 
of a trigeminal ganglia derived from mock and latently 
infected mice. In the experiment shown in Fig. 1A, the 
primers have been omitted, and no positive reactions are 
seen. In Fig. 1B, the complete reaction mixture was 
added, and approximately 20 positive cells are detected 
in a field of 50 neuronal cell bodies (arrowheads indicate 
examples of positive reactions). Figure 10 shows detec- 
tion of the a/I-I gene in HSV-l-infected tissue and again 
approximately 20 positive cells are seen in a field of 
25 neuronal cell bodies. Positive cells usually exhibited 
staining over entire cells but many did have specific nu- 
clear staining (data not shown). Total cellular staining 
was probably due to breakdown of nuclear membrane 
during reaction, as well as a result of the degree of 
development. Also, many cells exhibited "rim" like stain- 
ing; where staining occurred along the rim of the neuron. 
According to Long et al. (12) this effect was probably due 
to poor fixation. Total cellular staining was not thought 
to be the result of hybridization to RNA that survived the 
RNase treatment; since lack of primers resulted in no 
signal (Fig. 1A). Amplification with irrelevant primers (in 
the form of HSV-1 primer and probe set on mock-infected 
tissue as seen in Fig. 2B) or omission of Taq polymerase 
(data not shown) resulted in no positive reactions. This, 
coupled with the absence of signal when primers were 
omitted, further proved that the reaction was specific for 
the DNA detection of the single copy all-1 gene. Also, it 
must be noted that positive hybridization signals were 
usually accompanied by higher background. This in- 
creased background, relative to that seen when primers 
were omitted, was a characteristic of all trigeminal gan- 
glia sections that yielded a positive reaction. That is, the 
greater number of positive ceils, the greater the back- 
ground. This could be the result of leakage of amplified 
product or of the AEC (3'-amino-9'-ethylene carbozone) 
used in the development process. Reasons for this in- 
clude tissue damage from proteinase K steps and ther- 
mocycling, as well with poor fixationl However, 48% of the 
cells examined, per trigeminal ganglia, yielded positive 
reactions with the all-1 probe. Since the all-l gene is 
present in every cell in the section, the ability to detect 
a signal from 48% of cells suggests the system ap- 
proaches, but does not reach single copy detection sen- 
sitivity. The reasons for this are not known and may be 
related to tissue handling, amplification conditions, or 
irregularities in tissue sectioning. With 4-#m sections it 
.is possible that certain neurons contained no nuclei or 
only partial nuclei lacking the region containing the all- 
1 gene and hence could give no positive signal. Use of 
thicker tissue sections as well as the use of different 
amplification conditions (higher concentrations of nucle- 
otides, MgCI2, and primers) are un.derway and may result 
in better amplification throughout the ganglia. Neverthe- 
less, the system was able to detect nearly half of the 
single copy all-1 genes per cell population and gave us 
confidence that latent HSV-1 DNA would be detected. 
Moreover, since the all-1 primers used in the amplifica- 
tion were chosen for their similarity of G:C content to the 
HSV-1 primers, these initial experiments define, to some 
extent, the efficiency of the system. 
Since this assay was shown to be highly sensitive and 
specific, detection of the HSV-1 sequences in latently 
infected tissue was attempted. Figure 2 shows the re- 
sults of typical in situ DNA PCR analysis of HSV-1 se- 
quences in trigeminal ganglia from either mock or latently 
infected Balb/c mice. Figure 2A shows a section of gan- 
glia from mock-infected (uninfected) animals probed with 
HSV-1 specific primers and probes. No positive neurons 
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are seen in this example, which is typical. More than 
4000 neurons from mock-infected ganglia, derived from 
four different mice, were examined. Throughout five sep- 
arate experiments, mock tissue has consistently been 
free of any positive signals as well as being free of any 
background staining. Figures 2B and 2C show tissue 
from latently infected mice. The sample in Fig. 2B was 
amplified with irrelevant primers, specific for HBV (see 
4). Again, no specific hybridization signal is detected, 
demonstrating the specificity of this system. Slides ampli- 
fied with the HSV-1 primers but probed with the mouse 
all-1 probe also resulted in no signal (data not shown). 
Figure 2C shows sections of tissue from mice latently 
infected with HSV-1 and reacted with HSV-1 primers and 
probe. At least six positive neurons are shown. The sig- 
nals are red-pink in the absence of filters. Isolated posi- 
tives were also seen with regularity (Fig. 2D, arrowhead 
indicates positive cell). PCR reactions run on HSV-I-in- 
fected slides that had been treated with RNase showed 
no difference in detection of HSV-1 DNA (data not 
shown). As with the reactions run with the all-1 primers, 
an increase in the background was also seen when posi- 
tive reactions had taken place. 
More than 5000 neurons from 96 sections were 
counted from ganglia derived from four different mice 
using the method of Smoulden et al (21). This method 
attempts to measure the true number of neurons by con- 
sidering the number of neuronal nuclei, the diameter of 
the nucleus, and the thickness of the sections. Overall, 
hybridization to HSV-1 probe was detected in approxi- 
mately 4.8% of the 5000+ neurons examined. 
HSV-1 is routinely detected in latently infected tissue 
by probing for the expression of LAT, using an in situ 
RNA hybridization method (6, 17, 26). This method of in 
situ hybridization has been optimized by our group for 
the detection of LAT. Since in situ PCR methods sug- 
gested that approximately 4.8% of the neurons from la- 
tently infected mice were harboring HSV-1 DNA se- 
quences, it was of interest to know the number of neu- 
rons expressing LAT. Therefore, sections of trigeminal 
ganglia from the same regions used in the in situ PCR 
(above) were hybridized to LAT specific probe. Briefly, 
parrafin was removed from slides by placement in xylene 
for 5 min (twice) and then rehydrated by sequential place- 
ment in solutions of 95% ETOH, 70% ETOH, and 50% 
ETOH (for 5 min each) followed by a 5 min wash in l X 
PBS. Slides were then allowed to air dry overnight at 
room temperature. Sections were made permeable by 
placement in 0.2 N HCI for 20 min at room temperature 
followed by a 5-min room temperature wash in sterile 
double-distilled water. Tissue was then treated with 1 
#g/ml proteinase K (in 10 mM, pH 7.4, 2 mM CaOI2) for 
15 min at 37 °. After treatment, slides were washed twice 
in sterile double-distilled water for 5 min and dehydrated 
by sequential placement in 50, 70, and 90% ETOH for 5 
min each at room temperature. The slides were allowed 
to air dry before proceeding with the hybridization step. 
Hybridizations were performed in a solution of 45% de * 
ionized formamide, 2x  SSC, 10 mM Tris (pH 7.4), 1 mM 
EDTA, 1X Denhardts, 10% dextran sulfate, 1 mg/ml 
salmon sperm DNA, and 10 mM Dq-i-. The LAT probe 
was the 0.8-kb BstE2-BstE2 fragment of nucleotides 119, 
195 to 120,092 of the HSV-1 genome (16), radiolabeled 
with [5-35S]CTP by nick translation. The probe and meth- 
ods are further described in (3). Hybridization reactions 
took place in a humidified chamber at 50 ° for 24 hr. 
Posthybridization washes were as follows, (a) at 50 ° in 
a solution of 45% formamide, 2x  SSC, 1 mM Tris, pH 
7.4, 1 mM EDTA, for 5 min; (b) for 24 hr in 45% formamide, 
2× SSC, 1 mMTris, pH 7.4, 1 mM EDTA at room tempera- 
ture; (c) twice for 5 min each in 2X SSC at room tempera- 
ture. After washes, sections were dehydrated by sequen- 
tial placement in 0.3 M ammonium acetate in 70% ETOH 
(twice) and then 95% ETOH (twice). Slides were allowed 
to air dry and developed with emulsion solution as de- 
scribed previously (3). 
Typical results are shown in Fig. 3. There were no 
positive signals in neurons prepared from mock-infected 
mice (Fig. 3A). In the ganglia from latently infected mice, 
LAT hybridization is apparent over a neuronal nuclei (Fig. 
3B). There were 137 positive neurons in the 8000+ neu- 
rons examined, which were derived from the same four 
mice used in the PCR experiments described above. This 
level of LAT detection is consistent with that seen by 
others (6, 7, 27). Table 1 provides a summary of these 
data. 
FiG. 1. Detection of single copy sequences in mock infected and HSV-l-infected tissue by use of in situ PCR. Trigeminal ganglia were removed 
from mice that were either mock infected (A and B) or latently infected with HSV-1 (C) as in text. In addition, slides were treated with RNase before 
amplification. Single copy mouse sequences were amplified and hybridized using a primer and probe set to the murine all-1 gene (14). Amplified 
and hybridized products were detected by incubation with streptavidin-peroxidase nd developing solutions, as in text. Tissue was incubated 
either in PCR mix lacking primers (A) or in PCR mix containing murine all-1 primers (B) and (C). An example of a positive neuron is indicated with 
an arrowhead. Bar, 100 #m. 
Re. 2. Detection of HSV-1 sequences in trigeminal ganglia derived from latently infected mice by in situ PCR. Trigeminal ganglia were removed 
from mice that were either mock infected (A) or latently infected with HSV-1 (B, C, D). Trigeminal ganglia were prepared and sectioned as in text. 
HSV-1 sequences present in sections were amplified, in situ, and hybridized with a biotinylated probe. Amplified and hybridized products were 
detected by incubation with streptavidin-peroxidase nddeveloping solutions, as in text. Tissue from mice that were mock infected and incubated 
with HSV-1 specific primers (A). Tissue from mice that were latently infected and incubated with (B), HBV specific "irrelevant primers" or (C) and 
(D) HSV-1 specific primers. Positive neurons are present only in C and D. An example of a positive neuron is indicated by the arrowhead. (A, C, 
D) Bar, 50 #m. (B) Bar, 100 #m. 
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FIG. 3. Detection of HSV-1 LAT F{NA in trigemi.nal ganglia from latently infected mice by in situ hybridization. Slices of the same trigeminal ganglia 
used in Figs. 1 and 2 were hybridized to radioactively labeled probe specific for the HSV-1 LAT, as in text. Tissue from mock-infected (A) and 
latently infected (B) mice are shown. Positive signals are apparent as dark black grains (in B, see arrowhead). Bar, 200 #m in (A) and 100 #m 
in (B). 
Based upon the experiments described in this report, 
the fol lowing conclusions can be made. First, an in situ 
PCR system, using a DNA=DNA hybridization step, is an 
effective and sensitive means of detecting HSV-1 in the 
ganglia of latently infected mice. This detection does 
not depend upon expression of the viral genome, since 
RNase digestion of the tissue does not eliminate the 
signal (data not shown) and LAT null mutants which do 
not produce any transcripts in latently infected tissue can 
still be detected (data not shown). The ability to use in 
situ PCR to locate neurons harboring latent HSV-1 will 
be of enormous value in the study of virus pathogenesis. 
For example, this method wil l  al low for the tracking of 
virus that does not or cannot express LAT. This is the 
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TABLE 1 
NUMBER OF NEURONS SCORED AS POSITIVE 
Number of 
neurons d Number of neurons 
!nfection" P~imers D Probe c counted scored as positive 
A: In situ PCR= DNA hybridization 
HSV-1 (17) pol pol 5577 268 (4.8%) 
HSV-1 (17) HBV pol 916 0 (0%) 
HSV-1 (17) pol none 809 0 (0%) 
mock pol pol 4196 0 (0%) 
mock aft-/ aft-/ 635 305 (48%) 
mock none aft-/ 550 0 (0%) 
B: In situ RNA, DNA hybridization 
HSV-1 (17) LAT 8070 137 (1.6%) 
Mock LAT 6050 0 (0%) 
a Mice were infected with HSV-1 strain 17 or left uninfected (mock), 
as in text. 
b Primers for the in situ PCR reactions are homologous to the HSV- 
1 polymerase gene (pof), the hepatitis B virus genome (HBV), or the 
murine aft-/gene (see text). 
CThirty days after infection, mice were considered latently infected 
and sacrificed, as in text, Sections were prepared and assayed for 
HSV-1 DNA sequences by in s/tu POR (A) or RNA, DNA hybridization 
(8). Probes for in situ PCR amplified product and RNA, DNA hybridiza- 
tion product were either the HSV-1 polymerase gene (pol) or the murine 
alH gene and LAT gene sequence, respectively (see text). 
d Neuron counts were conducted using methods as in (21). 
first report of the use of in situ PCR for the detection of 
HSV-1 in latently infected murine trigeminal ganglia. 
Based upon the observations of a mouse sacral lum- 
bar model of HSV-1 latency, other investigators have 
shown that some neurons expressing viral antigens do 
not express LAT, and visa versa (15), suggesting that 
neurons behave heterogeneously with respect to the 
HSV-1 gene expression which will be supported in vivo. 
In another study, the ability of HSV-1 to establish latency 
in a neuron that had never experienced a productive 
infection was hypothesized (22). Neither study was able 
to determine the existence of latently infected cells in 
the absence of viral gene expression. It was of interest 
to observe that the number of neurons harboring HSV-1 
as detected, in this study, by in s/tu PCR is within an 
order of magnitude of the number detected by probing 
for LAT. Nevertheless, when the same ganglia, prepared 
in the same manner, was probed by in situ PCR either 
for HSV-1 DNA or for HSVq LAT, approximately 4.8 and 
1.6% of the neurons were found to be positive, respec- 
tively. The increased values of infected neurons detected 
by in situ PCR was consistent for most of the ganglia 
tested, and the value difference of 4.8% versus 1.6% is 
statistically significant (P < .001 by the X 2 test of signifi- 
cance). However, since single copy detection is only 50%, 
the actual percentage of HSV-1 DNA containing neurons 
may be closer to 9.6% then the observed 4.8%. That is, 
if all the HSV-1 containing neurons harbor only single 
copies of HSV-1 DNA, and our single copy detection is 
50%, than it is possible that the true number is twice as 
great as detected; that is closer to 9.6% then 4.8%. How- 
ever, if the number of neurons containing single copies 
of HSV-1 DNA is very small, with the majority of neurons 
containing multiple copies of HSV-1 DNA, then our detec- 
tion of 4.8% of neurons harboring HSV-1 is probably cor- 
rect. In any event our data does show that in the contexts 
of our mouse model of HSV-1 latency, between 4.8 and 
10% of neurons within any given trigeminal ganglia har- 
bor latent HSV-1 DNA. 
Thus, LAT expressing neurons represent a large sub- 
set of the total number of HSV-1 DNA containing neurons 
and may represent all DNA positive neurons. As the level 
of sensitivity offered by in situ PCR is much greater than 
that of in situ hybridization, detection of LAT positive 
neurons may be limited to those neurons harboring many 
copies of LAT. Although it has been estimated that there 
are between 2 x 10 4 and 2 X 105 LAT molecules per 
HSV-lqnfected cell (29), the possibility that some HSV- 
infected neurons harbor far fewer LAT molecules does 
exist. The precise minimum number of transcripts per cell 
that can be detected by the method of/n situ hybridization 
used is currently not fully known. However, the method 
has been successfully used to detect low abundance 
transcripts from mouse neurons (27). Therefore, it is pos- 
sible that all HSV-l-infected neurons, as detected by the 
in s/tu PCR, produce some amount of LAT. Dual labeling 
studies, using primer and probe sets for both LAT RNA 
and HSV-1 DNA, will be used to determine the true num- 
ber of LAT positive neurons and the role played by LAT 
in latency. 
Recently, reports have shown that /n sitzl PCR has 
been used to detect HSV-1 sequences in persistently 
infected corneal tissue (15) and HSV-2 sequences in la- 
tently infected central nervous tissue (9). It is interesting 
to note that in the latter group's detection of HSV-2 in 
trigeminal ganglia they were able to detect approximately 
four times the number of positives by in s/tu PCR than 
detected by in s/tu hybridization. Although this work was 
done with HSW2, and with the method of direct in situ 
PCR, these numbers compare favorably with our results 
and may indicate similar establishment profiles for the 
two types of herpes simplex virus. The ability to detect 
HSV-1 viral sequences without a requirement for gene 
expression will allow for the detection of LAT negative 
mutants and be of great value in the determination of 
the true nature of HSV-1 latency. 
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640 SHORT COMMUNICATIONS 
Note added in proolt During preparation of this manuscript, a report 
describing detection of HSV-1 DNA in the trigeminal ganglia of latently 
infected rats by direct in situ PCR was published (Ramakrishnan, R., 
Levine, M., and Fink, D. J., 1 ViroL 68, 7083-7091 (1994)). The general 
conclusions of that study are consistent with our observation that the 
number of neurons in lateqtly infected animals expressing detectable 
levels of LAT is a subset of the total HSV DNA positive population. 
However, those authors appeared to detect far greater a number of 
HSV DNA positive neurons compared to the number of LAT positive 
neurons. The reason(s) for these quantitative differences is under inves- 
tigation. 
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